Influenza Diagnostic Tests Market Size & Share Report, 2032

Influenza Diagnostic Tests Market - By Test Type (Traditional Diagnostic Test {RIDT, DFAT, Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, LAMP, NASBAT, SAMBA}), End-use & Forecast, 2023 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp; Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Influenza diagnostic tests industry 3600&nbsp;synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Test type trend

2.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Influenza Diagnostic Tests Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing prevalence of influenza

3.2.1.2&nbsp;&nbsp;&nbsp; Rise in demand for rapid diagnostic tests

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements

3.2.1.4&nbsp;&nbsp;&nbsp; Increase in R&amp;D activities

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Variabilities in test sensitivity and specificity

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory guidelines

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By test type

3.3.2&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.7&nbsp;&nbsp;&nbsp; Technology landscape

3.8&nbsp;&nbsp;&nbsp; GAP analysis

3.9&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Vendor matrix analysis

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Influenza Diagnostic Tests Market Size and Forecast, By Test Type (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key test type trends

5.2&nbsp;&nbsp;&nbsp; Traditional diagnostic test

5.2.1&nbsp;&nbsp;&nbsp; Rapid influenza diagnostic test (RIDT)

5.2.2&nbsp;&nbsp;&nbsp; Direct fluorescent antibody test (DFAT)

5.2.3&nbsp;&nbsp;&nbsp; Viral culture

5.2.4&nbsp;&nbsp;&nbsp; Serological assay

5.3&nbsp;&nbsp;&nbsp; Molecular diagnostic assay

5.3.1&nbsp;&nbsp;&nbsp; RT-PCR

5.3.2&nbsp;&nbsp;&nbsp; Loop-mediated isothermal amplification-based Assay (LAMP)

5.3.3&nbsp;&nbsp;&nbsp; Nucleic acid sequence-based amplification test (NASBAT)

5.3.4&nbsp;&nbsp;&nbsp; Simple amplification-based assay (SAMBA)

5.3.5&nbsp;&nbsp;&nbsp; Other molecular diagnostic assays

Chapter 6&nbsp;&nbsp;&nbsp;Influenza Diagnostic Tests Market Size and Forecast, By End-use (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key end-use trends

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.3&nbsp;&nbsp;&nbsp; Diagnostics centers

6.4&nbsp;&nbsp;&nbsp; Research laboratories

6.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 7&nbsp;&nbsp;&nbsp;Influenza Diagnostic Tests Market Size and Forecast, By Region (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key regional trends

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd

8.2&nbsp;&nbsp;&nbsp; Abbott

8.3&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

8.4&nbsp;&nbsp;&nbsp; Coris BioConcept

8.5&nbsp;&nbsp;&nbsp; DiaSorin SpA

8.6&nbsp;&nbsp;&nbsp; Meridian Bioscience Inc.

8.7&nbsp;&nbsp;&nbsp; Quidel Corporation

8.8&nbsp;&nbsp;&nbsp; Sekisui Diagnostics

8.9&nbsp;&nbsp;&nbsp; Thermo Fischer Scientific Inc.

8.10&nbsp;&nbsp;&nbsp; Hologic Inc. 
&nbsp;

Influenza Diagnostic Tests Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters